Search Within

Hematologic Malignancies, Division of

  1. "Massachusetts Medical Society"
Formats
  1. Journal Article (74)
  2. Correspondence (6)
  3. Editorial (4)
  4. Research Letter (2)
  5. Review (1)
Groups
  1. Department of Medicine (87)
  2. Center for Hematologic Malignancies (75)
  3. GSK Faculty (33)
  4. Adult Leukemia (31)
  5. Executive Committee, Center for Hematologic Malignancies (20)
  6. Tow Center for Developmental Oncology (TCDO) (19)

More Groups

People
  1. Ross Levine (9)
  2. Jae Park (8)
  3. Martin Tallman (8)
  4. Omar Abdel-Wahab (8)
  5. David Straus (6)
  6. Sergio Giralt (6)

More People

Years
  1. 2025 (4)
  2. 2024 (2)
  3. 2023 (9)
  4. 2022 (10)
  5. 2021 (3)
  6. 2020 (4)

More Years

Publications
  1. New England Journal of Medicine (84)
  2. NEJM Evidence (3)
Publishers
  1. Massachusetts Medical Society (87)

Results (87)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Rethinking cytarabine dosing in consolidation therapy for patients with AML
    Editorial

    Weinreb, J. T.; Abdel-Wahab, O.
    NEJM Evidence (2025)

    Fulltext@MSK | Save
  • Nonoperative management of mismatch repair-deficient tumors
    Journal Article

    Cercek, A.; Foote, M. B.; Rousseau, B.; Smith, J. J.; Shia, J.; Sinopoli, J.; Weiss, J.; Lumish, M.; Temple, L.; Patel, M.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Targeting the tumor and the immune system in smoldering multiple myeloma
    Editorial

    Maura, F.; Bergsagel, P. L.
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • CD4+ T-cell lymphoma harboring a chimeric antigen receptor integration in TP53
    Journal Article

    Perica, K.; Jain, N.; Scordo, M.; Patel, R.; Eren, O. C.; Patel, U.; Gundem, G.; Domenico, D.; Mitra, S.; Socci, N. D.; more...
    New England Journal of Medicine (2025)

    Fulltext@MSK | Save
  • Obecabtagene autoleucel in adults with B-cell acute lymphoblastic leukemia
    Journal Article

    Roddie, C.; Sandhu, K. S.; Tholouli, E.; Logan, A. C.; Shaughnessy, P.; Barba, P.; Ghobadi, A.; Guerreiro, M.; Yallop, D.; Abedi, M.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults
    Journal Article

    Litzow, M. R.; Sun, Z.; Mattison, R. J.; Paietta, E. M.; Roberts, K. G.; Zhang, Y.; Racevskis, J.; Lazarus, H. M.; Rowe, J. M.; Arber, D. A.; more...
    New England Journal of Medicine (2024)

    Fulltext@MSK | Save
  • Three-year overall survival with tebentafusp in metastatic uveal melanoma
    Journal Article

    Hassel, J. C.; Piperno-Neumann, S.; Rutkowski, P.; Baurain, J. F.; Schlaak, M.; Butler, M. O.; Sullivan, R. J.; Dummer, R.; Kirkwood, J. M.; Orloff, M.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Genetic basis of relapse after GPRCSD-targeted CAR T cells
    Research Letter

    Mi, X.; Penson, A.; Abdel-Wahab, O.; Mailankody, S.
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save
  • Vemurafenib and obinutuzumab as frontline therapy for hairy cell leukemia
    Journal Article

    Park, J. H.; Devlin, S.; Durham, B. H.; Winer, E. S.; Huntington, S.; von Keudell, G.; Vemuri, S.; Shukla, M.; Falco, V.; Cuello, B.; more...
    NEJM Evidence (2023)

    Fulltext@MSK | Save
  • Pembrolizumab plus chemotherapy in advanced endometrial cancer
    Journal Article

    Eskander, R. N.; Sill, M. W.; Beffa, L.; Moore, R. G.; Hope, J. M.; Musa, F. B.; Mannel, R.; Shahin, M. S.; Cantuaria, G. H.; Girda, E.; more...
    New England Journal of Medicine (2023)

    Fulltext@MSK | Save